BiotechnaS.A.Active
Research and experimental development on biotechnology
KRS: 0001002587 NIP: 9452226486 REGON: 38288257300000
Overview
Registry date
2022-11-16
Share capital
$34,544.30
Activity description
Biotechna is an innovative biotechnology company focused on developing targeted therapies using nanotechnology, specifically for oncology. They have created a nanoparticle platform for the delivery of nucleic acids and small molecules, addressing various cancers such as breast, lung, and brain tumors. Additionally, they are advancing RNA and DNA-based products to target undruggable cancer types and enhance treatment effectiveness while reducing toxicity.
Registered address
Ul. Bohdana Dobrzańskiego 3, 20-262 Lublin, Poland
Website
bsbiotechna.comWebsite active
Email
Email address current
Electronic delivery address
AE:PL-38682-35987-HGWAA-23
Industry
Accounts
Registered as a VAT taxpayer on 2019-07-04.Active
- 02 1090 1883 0000 0001 5934 4955
- 03 1020 1097 0000 7402 0818 5474
- 07 1020 2892 0000 5002 0711 7510
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| MedappS.A. | $3,351,163.61 | medapp.pl | |
| Read-GeneS.A. | $1,632,134.59 | read-gene.com | |
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | |
| GenxoneS.A. | $665,361.35 | genxone.eu | |
| Orphinic ScientificS.A. | $518,429.97 | orphinic.com | |
| DigitmedS.A. | $382,907.91 | digitmed.pl | |
| BiottsS.A. | $372,115.60 | biotts.com | |
| Medicofarma BiotechS.A. | $330,956.61 | medicofarmabiotech.pl | |
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | |
| Pure BiologicsS.A. | $149,394.35 | purebiologics.com |
FAQ
Last updated: 2026-07-11